Prescription Drug Benefits

121 Results

number of items to display at a time

Research

Jun 8, 2026

Generics in Medicaid Increased in Price and Shifted To Larger Manufacturers Amid 2022-2023 Amphetamine Shortage

We studied the impact of the 2022-2023 amphetamine shortage on spending, spending per prescription (i.e., prices), and dispensing of amphetamine products
Research

Nov 12, 2025

Designing And Evaluating Prescription Drug Models: Lessons From The Part D Senior Savings Model

The goal of this article is to apply our evaluation experiences to offer five design and evaluation considerations for future prescription drug models that the Innovation Center is interested in designing and testing.
Research

Sep 25, 2025

Part D Senior Savings Model Final Evaluation, 2021 to 2023

PDSS increased insulin use, adherence, and reduced out-of-pocket costs for users, while technology-enabled care evaluation identified implementation, data, and equity challenges, recommending methodological improvements and better data access.
Press

Sep 22, 2025

Program to Reduce Insulin Costs for Medicare Beneficiaries Has Cut Spending, Improved Diabetes Care

A three-year effort to reduce the cost of insulin for Medicare beneficiaries has achieved its primary goals, lowering out-of-pocket costs for the medication and increasing enrollees' regular use of insulin.
Sep 9, 2025

How RAND Helps Governments Save Money on Health Care: Recent Examples from RAND Health Research

For more than 60 years, RAND's analysis of health care issues has guided allocation of government resources, uncovered savings, found solutions to policy problems, and noted improved outcomes. This paper highlights some of those efforts.
Research

Jul 17, 2025

Medicare Part D Insulin Coverage: Formulary Strategies Amid Policy Headwinds

We found Part D plans are consolidating insulins onto Tier 3 but not broadly changing their utilization management tool strategies. This study demonstrates strategic adjustments that Part D plan sponsors may be making in response to policy changes.
Expert Insights

May 16, 2025

RAND Medicare Advantage and Part D Contract Star Ratings Technical Expert Panel: Summary of October 2024 Meeting

This document provides a summary of an October 2024 meeting to obtain input from technical experts on how the Centers for Medicare & Medicaid Services could streamline the Medicare Advantage and Part D Star Ratings measure set.
Research

Apr 14, 2025

Impact of Hospital-Physician Vertical Integration on Physician-Administered Drug Spending and Utilization

Vertical integration reduces care capacity, shifts care to hospital outpatient settings, and raises drug administration spending for hematology-oncology, ophthalmology, and rheumatology in Medicare. Drug spending also rises in hematology-oncology.
Research

Dec 5, 2024

Prescription Drug Prices, Rebates, and Insurance Premiums

The authors summarize evidence on drug spending, other health care costs, and premium trends in commercial markets. They also present findings from initial analyses of prescription drug data reported to the government by insurers and health plans.
Research

Nov 21, 2024

Trends in Medicare Part D Formulary Coverage for Non-insulin Diabetes Medications, 2020-2024

We assessed non-insulin diabetes drug coverage in Medicare Part D from 2020 to 2024.
Commentary

Oct 8, 2024

The Expense of Health Care Explained: What Americans Need to Know

Health care costs in the United States remain a critical concern for policymakers, providers, and patients alike. As voters head to the polls, we asked three experts on the economics of health care to explain some of the financial and public policy forces at work.
Commentary

Apr 17, 2024

Why Won't Health Insurance Companies Pay for New Drugs?

The FDA is prioritizing listening to patients by approving treatments quickly. So why are health insurers standing in the way?

First
Previous
Page 1 of 11
Next
Last

Prescription Drug Benefits

Prescription Drug Benefits

Related Topics

Explore RAND’s Work on this Topic

Error

Generics in Medicaid Increased in Price and Shifted To Larger Manufacturers Amid 2022-2023 Amphetamine Shortage

Designing And Evaluating Prescription Drug Models: Lessons From The Part D Senior Savings Model

Part D Senior Savings Model Final Evaluation, 2021 to 2023

Program to Reduce Insulin Costs for Medicare Beneficiaries Has Cut Spending, Improved Diabetes Care

How RAND Helps Governments Save Money on Health Care: Recent Examples from RAND Health Research

Medicare Part D Insulin Coverage: Formulary Strategies Amid Policy Headwinds

RAND Medicare Advantage and Part D Contract Star Ratings Technical Expert Panel: Summary of October 2024 Meeting

Impact of Hospital-Physician Vertical Integration on Physician-Administered Drug Spending and Utilization

Prescription Drug Prices, Rebates, and Insurance Premiums

Trends in Medicare Part D Formulary Coverage for Non-insulin Diabetes Medications, 2020-2024

The Expense of Health Care Explained: What Americans Need to Know

Why Won't Health Insurance Companies Pay for New Drugs?

Oops! An unexpected error has occurred.

RAND Headquarters

U.S. research divisions

International research divisions

Prescription Drug Benefits

Prescription Drug Benefits

Related Topics

Explore RAND’s Work on this Topic

Error

Generics in Medicaid Increased in Price and Shifted To Larger Manufacturers Amid 2022-2023 Amphetamine Shortage

Designing And Evaluating Prescription Drug Models: Lessons From The Part D Senior Savings Model

Part D Senior Savings Model Final Evaluation, 2021 to 2023

Program to Reduce Insulin Costs for Medicare Beneficiaries Has Cut Spending, Improved Diabetes Care

How RAND Helps Governments Save Money on Health Care: Recent Examples from RAND Health Research

Medicare Part D Insulin Coverage: Formulary Strategies Amid Policy Headwinds

RAND Medicare Advantage and Part D Contract Star Ratings Technical Expert Panel: Summary of October 2024 Meeting

Impact of Hospital-Physician Vertical Integration on Physician-Administered Drug Spending and Utilization

Prescription Drug Prices, Rebates, and Insurance Premiums

Trends in Medicare Part D Formulary Coverage for Non-insulin Diabetes Medications, 2020-2024

The Expense of Health Care Explained: What Americans Need to Know

Why Won't Health Insurance Companies Pay for New Drugs?

Oops! An unexpected error has occurred.